Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer-A Retrospective Study

NCT05023720 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT05023720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05023720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Effectiveness of Regorafenib in the Treatment of Patients With Metastatic Colorectal Cancer-A Retrospective Study
Lead sponsor
Henan Cancer Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 20, 2021
Completion date
December 21, 2022
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer